News in Brief
Certus expands Solus partnership with US distribution
The technology behind it is the company’s proprietary immunoassay based on enzyme linked immunosorbent assay (ELISA).
It is available in manual or a fully-automated, self-contained option (Solus DS2 Automated Laboratory ELISA), able to process 192 samples in one run including load-to-results on-screen instructions for technicians.
Ray Wakefield, CEO of Solus, said it gives American third party labs an AOAC validated alternative that this market is demanding.
“For food testing labs to use the Solus Pathogen Detection System makes both commercial and scientific sense, as we have enabled a proven technology to be automated, increasing throughput efficiency and productivity.”
Certus will launch its pathogen detection and environmental monitoring system early next year for Listeria spp.
The base technology is from a collaboration with BD (Becton, Dickinson and Company) and uses Surface-Enhanced Raman Spectroscopy (SERS).
Assay reagent and media development is between Certus and Solus Scientific.
John Coomes, Certus president, said the Solus system has the ability to increase lab productivity and efficiency.
“Labs across the country are in need of a powerful, efficient and cost effective system to ensure food is safe for everyone in our country.”